NEW YORK, April 4 (GenomeWeb News) - Collin D'Silva has resigned as chief executive officer of Transgenomic, the company said yesterday.
Michael Summers, the company's chief financial officer, has taken over as interim CEO until a new chief executive has been found. He also remains CFO.
D'Silva will remain chairman of the board of directors. He will manage strategic customer relationships and evaluate corporate strategic alternatives.
A company spokesperson did not cite a reason why D'Silva stepped down as CEO.